Article Information
PubMed
Published By
History
- Received April 7, 2021
- Revision received July 8, 2021
- Accepted July 13, 2021
- Published online July 22, 2021.
Copyright & Usage
Copyright © 2021 Nicholatos et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
Author Information
- Justin W. Nicholatos1,2,
- Joost Groot3,
- Shekhar Dhokai4,
- David Tran1,
- Lori Hrdlicka1,
- Thomas M. Carlile3,
- Melissa Bennion5,
- Isin Dalkilic-Liddle4,
- Warren D. Hirst1 and
- Andreas Weihofen1
- 1Neurodegeneration Research Unit, Biogen, Cambridge, MA 02142
- 2Biogen Postdoctoral Scientist Program, Biogen, Cambridge, MA 02142
- 3Translational Genome Sciences, Biogen, Cambridge, MA 02142
- 4Biologics Drug Discovery, Biogen, Cambridge, MA 02142
- 5Bioassays and High-Throughput Screens, Biogen, Cambridge, MA 02142
- Correspondence should be addressed to Andreas Weihofen at andreas.weihofen{at}biogen.com.
Author contributions
Author contributions: A.W., W.D.H., and J.W.N. designed research; A.W., J.W.N., D.T., L.H., T.M.C., S.D., M.B., I.D.-L., and J.G. performed research; M.B. contributed unpublished reagents/analytic tools; A.W., J.W.N., and J.G. analyzed data; A.W. and J.W.N. wrote the paper.
Disclosures
All authors are current or former employees of Biogen Inc.
Other Version
- You are viewing the most recent version of this article.
- previous version (July 22, 2021).






